| Fund ID | 805-6298445977 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 57% |
| Owned by non-U.S. persons | 100% |
| Fund | Type | Gross assets |
|---|---|---|
| Bpea Strategic Healthcare I-B, LP | Private Equity | $415.3M |
| Bpea Strategic Healthcare II, L.P. | Private Equity | $353.7M |
| Bpea VI, L.P. | Private Equity | $329.6M |
Brooke Private Equity Advisors Cayman Fund II, LP reports $13,255 in gross assets, among the top 100% of private funds by size.
The stated minimum investment is $500,000.
Brooke Private Equity Advisors Cayman Fund II, LP is managed by Brooke Private Equity Associates Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.